MAPT and Alzheimer disease: The impaired signal is further transduced to GSK3 enzyme involved in dysregulation of AD-linked Aβ homeostasis and tau hyperphosphorylation (Martinez and Perez 2013), but also in α-Syn-mediated neurodegeneration in PD (Yang et al. 2018).